Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

3,4,5
SC 13D/A

An amendment to a SC 13D filing

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
10-K/A

Amendment to a previously filed 10-K

Annual Filings
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings